GILEAD SCIENCES, INC. — Director's Dealing 2014

Dec 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-12-01

Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-01	Common Stock	M	30633	$24.295	Acquired	149327	Direct
2014-12-01	Common Stock	M	367	$23.755	Acquired	149694	Direct
2014-12-01	Common Stock	S	20700	$100.4640	Disposed	128994	Direct
2014-12-01	Common Stock	S	10300	$101.4386	Disposed	118694	Direct
2014-12-01	Common Stock	S	1400	$100.4508	Disposed	117294	Direct
2014-12-01	Common Stock	S	600	$101.4467	Disposed	116694	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-01	Non-Qualified Stock Option (right to buy)	$23.755	M	367	Disposed	2020-01-28	Common Stock (367)	Direct
2014-12-01	Non-Qualified Stock Option (right to buy)	$24.295	M	30633	Disposed	2022-01-26	Common Stock (30633)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

F4: Sale prices reported for the transactions reported here range from $99.93 to $100.8958. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: Sale prices reported for the transactions reported here range from $100.9513 to $101.7529. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F6: Sale prices reported for the transactions reported here range from $99.93 to $100.91. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F7: Sale prices reported for the transactions reported here range from $101.09 to $101.69. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.